Trevi Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
New Enterprise Associates reports a change in beneficial ownership percentage in Trevi Therapeutics due to an increase in the issuer's total outstanding shares.
NASDAQ
New Enterprise Associates (NEA) has filed an amendment to correct beneficial ownership disclosures for Trevi Therapeutics, Inc., reflecting prior warrant exercises.
NASDAQ
New Enterprise Associates (NEA) entities and affiliated managers have reported a decrease in their beneficial ownership of Trevi Therapeutics, Inc. common stock to 12.0% due to an increase in the total shares outstanding.
NASDAQ
SCHEDULE 13D/A: New Enterprise Associates Updates Trevi Therapeutics Stake, Percentage Ownership Declines Due to Share Dilution
New Enterprise Associates (NEA) has filed an Amendment No. 6 to its Schedule 13D, reporting a decrease in its beneficial ownership percentage of Trevi Therapeutics, Inc. common stock to 15.0% from a previously higher percentage, primarily due to an increase in the total number of outstanding shares.